DEERFIELD, Ill. / Jul 10, 2023 / Business Wire / Walgreens today announced a new weeklong shopping event, myW Days, which will take place July 23-29 for myWalgreens members. The event will offer unprecedented rewards and savings on all purchases in-store, online and in the Walgreens app. Since its launch in 2020, myWalgreens has become America’s largest free-to-join health and wellness loyalty program.
“We’re launching myW Days to thank myWalgreens members and show how much we appreciate them,” said Linh Peters, Chief Marketing Officer of Walgreens. “We know health and wellness is personal and needs change and vary, so our loyalty program is designed to provide valuable and flexible rewards across any Walgreens purchase. We’re excited to give our loyal shoppers even more of the rewards they already know and love during myW Days.”
myW Days rewards and savings
The member-only event will feature a week’s worth of offers and rewards and exclusive daily deals across the entire store; totaling more than $100 in myWalgreens Cash rewards* offers available per member. The ability to earn rewards will be available across thousands of products and services, with unique benefits for its most loyal members – including bonus earning opportunities and rewards accelerators.
Walgreens will announce specific myW Days savings and rewards deals on July 13. myWalgreens members will see the deepest rewards earning opportunities personalized to them, enabling them to stock up and save on their most shopped categories such as food and beverage, beauty and personal care, and everyday essentials. myWalgreens members can shop myW Days deals in any Walgreens store, on Walgreens.com or in the Walgreens app. Online purchases are also available for in-store pickup and 1-Hour Delivery.
myWalgreens history of rewarding members
myWalgreens provides members with an easier way to save money and time, shop conveniently and stay well. Members can earn up to $400 in Walgreens Cash rewards every year by participating in offers. The program is free and simple to join and unlocks sale prices and rewards members with Walgreens Cash rewards on all purchases.
Anyone can sign up for myWalgreens at any of Walgreens nearly 9,000 stores or online at Walgreens.com/myWalgreens.
*$100 Walgreens Cash rewards is based on members taking advantage of the available offers each day of myW™ days. Complete details, including Walgreens Cash rewards expiration dates, at myWalgreens.com.
About Walgreens
Walgreens (www.walgreens.com) is included in the U.S. Retail Pharmacy and U.S. Healthcare segments of Walgreens Boots Alliance, Inc. (Nasdaq: WBA), an integrated healthcare, pharmacy and retail leader with a 170-year heritage of caring for communities. WBA’s purpose is to create more joyful lives through better health. Operating nearly 9,000 retail locations across America, Puerto Rico and the U.S. Virgin Islands, Walgreens is proud to be a neighborhood health destination serving nearly 10 million customers each day. Walgreens pharmacists play a critical role in the U.S. healthcare system by providing a wide range of pharmacy and healthcare services, including those that drive equitable access to care for the nation’s underserved populations. To best meet the needs of customers and patients, Walgreens offers a true omnichannel experience, with fully integrated physical and digital platforms supported by the latest technology to deliver high-quality products and services in communities nationwide.
Last Trade: | US$10.89 |
Daily Change: | 0.09 0.83 |
Daily Volume: | 7,508,331 |
Market Cap: | US$9.410B |
March 06, 2025 January 10, 2025 December 13, 2024 October 15, 2024 |
Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...
CLICK TO LEARN MOREAstria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...
CLICK TO LEARN MOREEnd of content
No more pages to load